Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
3
75%
Ph not_applicable
1
25%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 13 (75.0%)
N/A1 (25.0%)

Trials by Status

completed375%
active_not_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruitingphase_1

Transfer of Genetically Engineered Lymphocytes in Melanoma Patients

NCT01586403
completedphase_1

Vitamin D Levels Following Topical Application of Vitamin D Ointment

NCT02676674
completedphase_1

Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.)

NCT02088203
completednot_applicable

Effects of Polyphenols Found in Pomegranate and Olives Food Supplements on Postprandial Blood Glucose in Vivo.

NCT02486978

Clinical Trials (4)

Showing 4 of 4 trials
NCT01586403Phase 1

Transfer of Genetically Engineered Lymphocytes in Melanoma Patients

Active Not Recruiting
NCT02676674Phase 1

Vitamin D Levels Following Topical Application of Vitamin D Ointment

Completed
NCT02088203Phase 1

Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.)

Completed
NCT02486978Not Applicable

Effects of Polyphenols Found in Pomegranate and Olives Food Supplements on Postprandial Blood Glucose in Vivo.

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4